News

August 4, 2017

Soft Robotic Exosuit Could Help Those with Parkinson’s, a Stroke Patient Study Indicates

News

A Harvard University-designed soft robotic exosuit that helped stroke patients walk better could do the same for Parkinson’s and multiple sclerosis patients, those involved in creating and evaluating the ... Read more

August 3, 2017

Parkinson’s Foundation Starts Podcast Series on Research, Advice and Other Subjects

News

The Parkinson’s Foundation has started a podcast series on new research findings, advice for those with the disease and their families, and other topics. The podcasts, hosted by Dr. Dan Keller, are ... Read more

August 2, 2017August 2, 2017

Friends Pedaling for Parkinson’s Reach New Milestone, Raise $1M for Research

News

Peter Istvan and David Newall founded “Pedaling for Parkinson’s” in 2011 as an annual cycling fundraising event to support Parkinson’s Canada and the Parkinson’s disease (PD) community. This year, “Pedaling ... Read more

August 1, 2017August 1, 2017

Free Water Molecules in Brain Region Could Help Track Parkinson’s Progression, Study Suggests

News

Quantifying changes in fluid in a specific brain area, using a magnetic resonance imaging (MRI)-based method, could provide a way to track brain damage in patients with Parkinson’s disease, a new ... Read more

July 31, 2017July 31, 2017

New Digital Cognitive Assessment Tool Receives Positive FDA Review

News

The cognitive science company Cogstate received approval to market a new digital cognitive assessment tool to assist healthcare professionals in measuring cognition in patients ages 6 to 99, either in-clinic or at ... Read more

July 29, 2017

Free Water Levels Provide a New Biomarker for Parkinson’s Disease Progression

News

According to a recent study, a newly discovered biomarker, free water, can track changes in the brain that are associated with Parkinson’s disease, which ultimately may aid in developing new drugs ... Read more

July 28, 2017

Prexton Therapeutics Initiates Phase 2 Trial of Foliglurax for Parkinson’s Patients

News

Prexton Therapeutics has initiated a new Phase 2 clinical trial to assess the safety and effectiveness of its investigational therapy Foliglurax (PXT002331) in Parkinson’s disease patients treated with levodopa, but who are experiencing ... Read more

July 27, 2017

Forbes Includes Maker of Nuplazid on List of Most Innovative Growth Companies

News

Acadia Pharmaceuticals, the maker of Nuplazid (pimavanserin), an oral medication to treat hallucinations and delusions associated with Parkinson’s disease (PD), was ranked 11th on Forbes Magazine’s 2017 list of ... Read more

July 26, 2017

Workings of Key Protein That Affects Neuron Signaling in Brain Seen in Study

News

Researchers are one step closer to fully understanding how a group of proteins, called the AMPA receptors, work — potentially gaining an insight into how neurological diseases like Parkinson’s ... Read more

July 25, 2017

Parkinson’s Disease Patients Offer Their Top Tips for Living Well With the Condition

In this video from Parkinson’s UK, people living with Parkinson’s disease talk about the effect the condition has had on their lives and offer some tips for anyone who ... Read more